APA (7th ed.) Citation

Mak, A., Nasir, N., & Cho, J. (2024). POS0731 IDENTIFICATION OF AUTOANTIBODY SIGNATURES AND BIOMARKERS OF DISEASE ACTIVITY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) USING HIGH-THROUGHPUT PROTEOMIC MICROARRAYS. Annals of the rheumatic diseases, 83(Suppl 1), 997-998. https://doi.org/10.1136/annrheumdis-2024-eular.4053

Chicago Style (17th ed.) Citation

Mak, A., N. Nasir, and J. Cho. "POS0731 IDENTIFICATION OF AUTOANTIBODY SIGNATURES AND BIOMARKERS OF DISEASE ACTIVITY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) USING HIGH-THROUGHPUT PROTEOMIC MICROARRAYS." Annals of the Rheumatic Diseases 83, no. Suppl 1 (2024): 997-998. https://doi.org/10.1136/annrheumdis-2024-eular.4053.

MLA (9th ed.) Citation

Mak, A., et al. "POS0731 IDENTIFICATION OF AUTOANTIBODY SIGNATURES AND BIOMARKERS OF DISEASE ACTIVITY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) USING HIGH-THROUGHPUT PROTEOMIC MICROARRAYS." Annals of the Rheumatic Diseases, vol. 83, no. Suppl 1, 2024, pp. 997-998, https://doi.org/10.1136/annrheumdis-2024-eular.4053.